It has been well established that Wnt and MAPK pathways account for CRC progression and metastases [13, 25, 27], and the presence of APC, KRAS, BRAF, PIK3CA, SMAD4 and TP53 mutations closely relates to treatment decision and prognosis. Here, PIK3CA is linked to colorectal carcinoma.